%D9%86%D9%82%D8%B5_%D8%BA%D8%A7%D9%85%D8%A7_%D8%BA%D9%84%D9%88%D8%A8%D9%88%D9%84%D9%8A%D9%86_%D8%A7%D9%84%D8%AF%D9%85Hypogammaglobulin%C3%A4mieHypogammaglobulinemiaHipogammaglobulinemia%D0%90%D0%B3%D0%B0%D0%BC%D0%BC%D0%B0%D0%B3%D0%BB%D0%BE%D0%B1%D1%83%D0%BB%D0%B8%D0%BD%D0%B5%D0%BC%D0%B8%D1%8FQ1047559
about
sameAs
Quality of Life and Neuropsychiatric Sequelae in Patients Treated With Gene Therapy for ADA-SCID and in Their ParentsBioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency DiseasesEZN-2279 in Patients With ADA-SCIDSubcutaneous Ig in Allogeneic Stem Cell Transplant RecipientsRegistry Study of Revcovi Treatment in Patients With ADA-SCIDLentiviral Gene Therapy for Adenosine Deaminase (ADA) DeficiencyA Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary ImmunodeficiencyPlerixafor Versus G-CSF in the Treatment of People With WHIM SyndromePost-bypass Prophylactic IVIG in Infants and NeonatesTreatment of SCID Due to ADA Deficiency With Autologous Transplantation of Cord Blood or Hematopoietic CD 34+ Cells After Addition of a Normal Human ADA cDNA by the EFS-ADA Lentiviral VectorInvestigation of Immune Disorders and DeficienciesMutation of the BTK Gene and Genotype-phenotype Correlation of Chinese Patients With X-Linked AgammaglobulinemiaLenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID)Specific IgG Antibody in Patients With Primary Antibody Deficiencies Treated With Subcutaneous ImmunoglobulinPersonalized Immunotherapeutic for Antibiotic-resistant InfectionPharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency DiseasesGene Therapy ADA DeficiencyLenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaStudy of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement TherapyEfficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary ImmunodeficiencySafety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)Clinical and Virological Efficacy of Pegylated Interferon Alpha in the Treatment of Rhinovirus Infection in Patients With Primary Hypogammaglobulinemia: Randomized Controlled TrialEfficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency PatientsEfficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID)Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia)Kinetics, Efficacy and Safety of IVIG-L in Hypogammaglobulinemia PatientsCytomegalovirus Hyperimmune Globulin (CMV-Ig) Replacement in Hypogammaglobulinemic Lung Transplant RecipientsIntravenous Immunoglobulin (IVIG) in Lung TransplantationTotal-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow TransplantAllogeneic Bone Marrow Transplantation in Patients With Primary ImmunodeficienciesStudy of Genetic and Molecular Defects in Primary Immunodeficiency DisordersAssessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and OlderImmune Disorder HSCT ProtocolAn Observational LTFU Study for Patients Previously Treated With Autologous ex Vivo Gene Therapy for ADA-SCIDRituximab-Induced Hypogammaglobulinemia in Multiple Sclerosis
P1050
P1889
common variable immunodeficiencyB cell linker protein deficiencyGood syndromecongenital hypogammaglobulinemiatransient hypogammaglobulinemiaActivated PI3K Delta SyndromeBruton-type agammaglobulinemiaagammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndromeisolated agammaglobulinemiasyndromic agammaglobulinemiaagammaglobulinemia
P279
Educational paper: primary antibody deficienciesGene therapy for PIDs: progress, pitfalls and prospectsSplice-correction strategies for treatment of X-linked agammaglobulinemia.First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature.Adenosine deaminase deficiency: a review.
P921
Q61864941-F999E9BA-3509-4CA3-8973-7F8AF82D5F83Q61975950-D31CF78F-D3AB-4E43-BE32-8FB2B80FCC35Q63322243-96406F0F-696C-4507-912D-8E19C37E2D19Q63405590-CE096C6D-DFA2-4AC6-83EA-0B3DB8C8D5C4Q63808379-5E8CF932-E28A-478F-A751-FFCC7ADAA435Q63812170-62A79B83-E406-407A-9AFB-F350B081977AQ63814218-464C3794-8A16-46DD-B9DE-1DA7DCE95602Q64151797-AED29DF0-08C0-4E41-9376-935AF0476B15Q64348747-E1ECF967-A7C3-4173-A51B-2CF436EE7A5DQ64350169-1E84C900-17BC-4F7D-BE25-D7F9B2413466Q64352416-3DEB34AF-E88A-4518-86ED-6B9C533ECB55Q64603216-A0DE47DA-70AA-4F6A-85C8-B48B526ABB96Q64621823-9A03EF3C-4901-4B99-BDDE-A8CF48A0934EQ64644401-06964BE4-500F-456B-8C45-CAE0EEFCBCE2Q64720639-1F701E1E-37F4-4D5D-9C18-F45F232E0CADQ65339468-D50B518B-138B-4CBF-97FD-CC12522E5C7EQ65362091-5915A192-943F-4B6F-BAA3-102E998F8908Q65375796-E4DC0DE8-2BA5-475E-A886-0559DDA0BD7EQ65376926-40477806-8668-4299-836B-F17618792BEFQ65379917-28FF9419-04DB-468C-A73C-D835052DBA4FQ65382669-F25028A1-12CA-4E05-93C8-7BD437A702FEQ65389965-522637A4-C19D-4110-9ACA-884854E4ED13Q65465965-68A34230-2A43-4AA5-BA19-4C657663EAF0Q65538851-4C731A73-54C6-4CB2-93E3-C791C386429EQ65543911-8779818E-BE5B-4930-A159-DA7948E059F3Q66026315-A390185C-B465-47C1-BE98-CDF6B73B216EQ66026317-9599210C-C8D6-4DC3-BF9C-DF9BDA698A86Q66027240-1F1FC626-E8C2-41DB-9E3B-98FA31DE782FQ66028843-BE40E2FC-D34B-40A5-89CC-B4B2B2910B0FQ66029027-14F8B4B9-9A37-4E18-8854-E9985BAC18FFQ66033476-D25B6A97-597C-4A95-8382-04C55C3426F0Q66059864-0C4DC932-4499-4E10-B916-58029DF03CBCQ66060096-D42A26AF-C741-4CA0-8D84-4721214FEE02Q66062050-68FED8F7-F202-4124-9884-6EF40AA3F62AQ66079881-BF929775-39AA-477A-9E90-0856D5543710Q66344455-A37FB9E0-0318-48BD-AD1A-4613ACC1BF7CQ66387389-6D89D28C-D3FA-42E4-B490-39AC1049B4E8Q87930543-D53EAEC5-A438-43CA-AE79-5263130800C1
P1050
description
B cell deficiency that is caused by a reduction in all types of gamma globulins
@en
Krankheit
@de
Μη φυσιολογική μείωση στην παραγωγή ανοσοσφαιρινών.
@el
name
Agammaglobwlïnemïya
@kk-latn
Hypogammaglobulinämie
@de
agammaglobulinemia
@en
hipogammaglobulinemia
@es
hipogammaglobulinèmia
@ca
hypogammaglobulinémie
@fr
υπόγαμμασφαιριναιμία
@el
Агаммаглобулинемия
@kk
Агаммаглобулинемия
@kk-cyrl
اگامماگلوبۋلىينەمىييا
@kk-arab
type
label
Agammaglobwlïnemïya
@kk-latn
Hypogammaglobulinämie
@de
agammaglobulinemia
@en
hipogammaglobulinemia
@es
hipogammaglobulinèmia
@ca
hypogammaglobulinémie
@fr
υπόγαμμασφαιριναιμία
@el
Агаммаглобулинемия
@kk
Агаммаглобулинемия
@kk-cyrl
اگامماگلوبۋلىينەمىييا
@kk-arab
altLabel
IGHM
@en
hypogammaglobulinemia
@en
mu heavy chain deficiency
@en
عوز غاما غلوبولين الدم
@ar
نقص غاماجلوبولين الدم
@ar
低丙种球蛋白血症
@zh-cn
低丙種球蛋白血症
@zh
低丙種球蛋白血症
@zh-hans
prefLabel
Agammaglobwlïnemïya
@kk-latn
Hypogammaglobulinämie
@de
agammaglobulinemia
@en
hipogammaglobulinemia
@es
hipogammaglobulinèmia
@ca
hypogammaglobulinémie
@fr
υπόγαμμασφαιριναιμία
@el
Агаммаглобулинемия
@kk
Агаммаглобулинемия
@kk-cyrl
اگامماگلوبۋلىينەمىييا
@kk-arab
P2293
P2888
P2892
P492
P672
P486
P6366
P1417
science/hypogammaglobulinemia
P1461
Hypogammaglobulinaemia
P1550
P1692
P1748
P1889
P1995
P2892
P3841
HP:0004313
HP:0004432
P4229
P486
P492
P5270
MONDO:0015977